|
|
||||||||
Departments of Radiology and Internal Medicine, University of California, Davis, Medical Center, Sacramento, California
Correspondence: For reprints contact: Robert C. Stadalnik, MD, Division of Nuclear Medicine, University of California, Davis, Medical Center, 2315 Stockton Blvd., Sacramento, CA 95817.
ABSTRACT
Hepatic binding protein (HBP) is a hepatocyte-specific recaptor for serum asialoglycoproteins. The receptor also recognizes a synthetic glycoprotein that has been developed as a radiopharmaceutical, technetium-99m-galactosyl-neoglycoalbumin (99mTc-NGA). This report describes the correlation between receptor parameters measured in vivo via kinetic modeling of 99mTc-NGA and those measured by in vitro radioassay of biopsied liver tissue. Eleven patients with diffuse hepatic disease underwent percutaneous liver biopsy followed by a 99mTc-NGA functional imaging study. In vivo measurements of HBP quantity Ro and forward binding rate constant kb obtained from the kinetic analysis of 99mTc-NGA liver and blood time-activity data were compared to total receptor quantity and the HBP-99mTc-NGA association constant KA as measured by Scatchard binding assay of the biopsied tissue. The correlation coefficients between in vivo and in vitro measurements were 0.73 (df=8, p=0.015) and 0.98 (df=8, p< 0.01) for Ro and kb, respectively. The in vivo measurements of HBP biochemistry via kinetic analysis of the radiopharmaceutical time-activity data reflect the average concentration and affinity of the receptor. This study further substantiates the validity of 99mTc-NGA as a quantitative probe for the HBP receptor.
This article has been cited by other articles:
![]() |
N. Shuke, A. Okizaki, S. Kino, J. Sato, Y. Ishikawa, C. Zhao, S. Kinuya, N. Watanabe, K. Yokoyama, and T. Aburano Functional Mapping of Regional Liver Asialoglycoprotein Receptor Amount from Single Blood Sample and SPECT J. Nucl. Med., March 1, 2003; 44(3): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Colquhoun, C. A. Connelly, and D. R. Vera Portal-Systemic Shunts Reduce Asialoglycoprotein Receptor Density in Rats J. Nucl. Med., January 1, 2001; 42(1): 110 - 116. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |